These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7573315)

  • 1. Lichen planus associated with topical beta-blocker therapy.
    Beckman KA; Chanes L; Kaufman SR
    Am J Ophthalmol; 1995 Oct; 120(4):530-1. PubMed ID: 7573315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic contact dermatitis due to timolol and levobunolol in eyedrops, with no cross-sensitivity to other ophthalmic beta-blockers.
    Koch P
    Contact Dermatitis; 1995 Aug; 33(2):140-1. PubMed ID: 8549145
    [No Abstract]   [Full Text] [Related]  

  • 4. Contact dermatitis due to levobunolol in eyedrops.
    Garcia F; Blanco J; Juste S; Garces MM; Alonso L; Marcos ML; Carretero P; Perez R
    Contact Dermatitis; 1997 Apr; 36(4):230. PubMed ID: 9165213
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma.
    Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777
    [No Abstract]   [Full Text] [Related]  

  • 6. Contact dermatitis from levobunolol eyedrops.
    Erdmann S; Hertl M; Merk HF
    Contact Dermatitis; 1999 Jul; 41(1):44-6. PubMed ID: 10416712
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradyarrhythmias secondary to topical levobunolol hydrochloride solution.
    Lin L; Wang Y; Chen Y; Liu M
    Clin Interv Aging; 2014; 9():1741-5. PubMed ID: 25342892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine.
    David R; Ober M; Masi R; Elman J; Novack GD; Sears ML; Batoosingh AL
    Can J Ophthalmol; 1987 Jun; 22(4):208-11. PubMed ID: 2886200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case against treating glaucoma.
    Fraser H
    Aust N Z J Ophthalmol; 1995 May; 23(2):159. PubMed ID: 7546695
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker eye drops.
    Nurs Times; 2006 May 30-Jun 5; 102(22):29. PubMed ID: 16764382
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of erosive lichen planus with topical tacrolimus and recurrence secondary to metoprolol.
    Meyer S; Burgdorff T; Szeimies RM; Vogt T; Landthaler M; Karrer S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):236-9. PubMed ID: 15752301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
    Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B
    Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of unoprostone isopropyl as an adjunct to topical beta-blocker in patients with open angle glaucoma: a-6-month study.
    Leelachaikul Y; Euswas A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S100-4. PubMed ID: 16681060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile.
    Broadway DC; Grierson I; O'Brien C; Hitchings RA
    Arch Ophthalmol; 1994 Nov; 112(11):1437-45. PubMed ID: 7980133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
    Halper LK; Johnson-Pratt L; Dobbins T; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis due to levobunolol with cross-sensitivity to befunolol.
    Nino M; Balato A; Ayala F; Balato N
    Contact Dermatitis; 2007 Jan; 56(1):53-4. PubMed ID: 17177718
    [No Abstract]   [Full Text] [Related]  

  • 19. Lichen planus-like drug eruptions due to β-blockers: a case report and literature review.
    Fessa C; Lim P; Kossard S; Richards S; Peñas PF
    Am J Clin Dermatol; 2012 Dec; 13(6):417-21. PubMed ID: 22809321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report of sweating associated with topical beta-blocker therapy.
    Schmutz JL; Barbaud A; Reichert S; Vasse JP; Trechot P
    Dermatology; 1997; 194(2):197-8. PubMed ID: 9094480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.